| Genomic hallmarks and structural variation in metastatic prostate cancer DA Quigley, HX Dang, SG Zhao, P Lloyd, R Aggarwal, JJ Alumkal, A Foye, ... Cell 174 (3), 758-769. e9, 2018 | 848 | 2018 |
| The DNA methylation landscape of advanced prostate cancer SG Zhao, WS Chen, H Li, A Foye, M Zhang, M Sjöström, R Aggarwal, ... Nature genetics 52 (8), 778-789, 2020 | 352 | 2020 |
| Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of BRCA2 Reversion Mutations Associated with Resistance to PARP Inhibitors D Quigley, JJ Alumkal, AW Wyatt, V Kothari, A Foye, P Lloyd, R Aggarwal, ... Cancer discovery 7 (9), 999-1005, 2017 | 303 | 2017 |
| The immune landscape of prostate cancer and nomination of PD-L2 as a potential therapeutic target SG Zhao, J Lehrer, SL Chang, R Das, N Erho, Y Liu, M Sjöström, RB Den, ... JNCI: Journal of the National Cancer Institute 111 (3), 301-310, 2019 | 195 | 2019 |
| Validation of a 22-gene genomic classifier in patients with recurrent prostate cancer: an ancillary study of the NRG/RTOG 9601 randomized clinical trial FY Feng, HC Huang, DE Spratt, SG Zhao, HM Sandler, JP Simko, ... JAMA oncology 7 (4), 544-552, 2021 | 160 | 2021 |
| Novel androgen receptor coregulator GRHL2 exerts both oncogenic and antimetastatic functions in prostate cancer S Paltoglou, R Das, SL Townley, TE Hickey, GA Tarulli, I Coutinho, ... Cancer research 77 (13), 3417-3430, 2017 | 134 | 2017 |
| MicroRNA-194 promotes prostate cancer metastasis by inhibiting SOCS2 R Das, PA Gregory, RC Fernandes, I Denis, Q Wang, SL Townley, ... Cancer research 77 (4), 1021-1034, 2017 | 130 | 2017 |
| A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer LA Selth, R Das, SL Townley, I Coutinho, AR Hanson, MM Centenera, ... Oncogene 36 (1), 24-34, 2017 | 119 | 2017 |
| Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality Oncogene doi: 10.1038/onc.2016.482, 2017 | 98* | 2017 |
| Lipidomic profiling of clinical prostate cancer reveals targetable alterations in membrane lipid composition LM Butler, CY Mah, J Machiels, AD Vincent, S Irani, SM Mutuku, ... Cancer research 81 (19), 4981-4993, 2021 | 83 | 2021 |
| Grand Challenges in global eye health: a global prioritisation process using Delphi method J Ramke, JR Evans, E Habtamu, N Mwangi, JC Silva, BK Swenor, ... The Lancet Healthy Longevity 3 (1), e31-e41, 2022 | 61 | 2022 |
| Post-transcriptional gene regulation by MicroRNA-194 promotes neuroendocrine transdifferentiation in prostate cancer RC Fernandes, J Toubia, S Townley, AR Hanson, BK Dredge, KA Pillman, ... Cell reports 34 (1), 2021 | 51 | 2021 |
| Can we use eplets (or molecular) mismatch load analysis to improve organ allocation? The hope and the hype AR Tambur, R Das Transplantation 107 (3), 605-615, 2023 | 45 | 2023 |
| An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer R Das, M Sjöström, R Shrestha, C Yogodzinski, EA Egusa, LN Chesner, ... Nature Communications 12 (1), 4601, 2021 | 42 | 2021 |
| Association of imputed prostate cancer transcriptome with disease risk reveals novel mechanisms SKVDEJSW Nima C. Emami, Linda Kachuri, Travis J. Meyers, Rajdeep Das, Joshua ... Nature Communications 10, 2019 | 39 | 2019 |
| Identification of novel response and predictive biomarkers to Hsp90 inhibitors through proteomic profiling of patient-derived prostate tumor explants EV Nguyen, MM Centenera, M Moldovan, R Das, S Irani, AD Vincent, ... Molecular & Cellular Proteomics 17 (8), 1470-1486, 2018 | 37 | 2018 |
| Foot ulcers and risk factors among diabetic patients visiting Surgery Department in a University Teaching Hospital in Ajman, UAE V Manda, J Sreedharan, J Muttappallymyalil, R Das, E Hisamatsu International Journal of Medicine and Public Health 2 (3), 34-38, 2012 | 37 | 2012 |
| Epithelial plasticity in prostate cancer: principles and clinical perspectives R Das, PA Gregory, BG Hollier, WD Tilley, LA Selth Trends in molecular medicine 20 (11), 643-651, 2014 | 33 | 2014 |
| Androgen receptor inhibition increases MHC Class I expression and improves immune response in prostate cancer LN Chesner, F Polesso, JN Graff, JE Hawley, AK Smith, A Lundberg, ... Cancer discovery 15 (3), 481-494, 2025 | 31 | 2025 |
| Age and gender based utilisation pattern of antidiabetic drugs in Ajman, United Arab Emirates L John, M Arifulla, J Sreedharan, J Muttappallymyalil, R Das, J John, ... Malaysian J Pharma Sc 10 (1), 79-85, 2012 | 31 | 2012 |
Luke A. SelthProfessor of Cancer Biology at Flinders UniversityVerified email at flinders.edu.au
